Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case: Table 1.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.